Why the study?
Does carotid baroreceptor stimulation reduce blood pressure in patients with resistant hypertension?
Does carotid baroreceptor stimulation reduce blood pressure in patients with resistant hypertension?
Carotid baroreceptor stimulation is emerging as a promising device-based treatment alternative for resistant hypertension.
May support baroreceptor stimulation in resistant hypertension; leaves open long-term efficacy and guideline integration.
Resistant hypertension indicates that the blood pressure cannot reach the target value despite standard drug treatment, which harbors an increased risk for cardiovascular diseases. The role of the carotid sinus in regulating blood pressure has long been observed; thereby, the idea that treating resistant hypertension by stimulating carotid baroreceptors emerged. Nevertheless, this idea has been abandoned for years due to technical limitations. Recently, with the evolutions in implantable electrical devices, expectations for treating resistant hypertension with baroreceptor stimulation have increased. Positive results from several multicenter clinical trials further captured the researchers' enthusiasm for more effective baroreceptor-stimulating devices. This study reviews the recent progress in baroreceptor stimulation as a treatment alternative for resistant hypertension.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: